LAMEA Patient-Controlled Analgesic Pumps Market By Type (Electronic and Mechanical), By Application (Oncology, Diabetes, Hematology, Gastroenterology and Others), By End-use (Hospitals, Specialty Clinics and Ambulatory Surgical Centers), By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the LAMEA Patient-Controlled Analgesic Pumps Market
The Latin America, Middle East and Africa Patient-controlled Analgesic Pumps Market would witness market growth of 10.6% CAGR during the forecast period (2021-2027).
Patient-controlled analgesic pumps find potential application during post-surgical recovery as they offer an effective and reliable method of pain management in comparison to the frequent analgesic injections. Moreover, with the help of PCA pumps, patients become empowered to deliver doses of narcotics intravenously only by pressing the push button. These pumps are also helpful in quick recovery and pain management after going through surgery.
Using these pumps, the requirement for intramuscular injections can be reduced or eliminated. These pumps are beneficial in reducing patient anxiety, providing superior analgesic effects, and considerable improvements in pulmonary complications in comparison to other types of analgesics. Therefore, the market would witness lucrative growth opportunities due to various benefits of PCA pumps such as higher patient satisfaction, a smaller number of post-operative complications, and higher pain relief effects.
Increment in the occurrence of chronic pain diseases such as cancer, rheumatoid arthritis, and fibromyalgia is expected to create growth avenues for the global PCA pumps market in the next few years. According to the report by MD Anderson Cancer Center in January 2020, the majority of cancer patients suffer from chronic non-malignant pain around the world, which mandates efficient pain management treatment.
The Oncology market dominated the UAE Patient-Controlled Analgesic Pumps Market by Application in 2020, growing at a CAGR of 8.8% during the forecast period. The Diabetes market is showcasing a CAGR of 9% during (2021 - 2027). Additionally, The Hematology market is expected to witness highest CAGR of 10.8% during (2021 - 2027).
Based on Type, the market is segmented into Electronic and Mechanical. Based on Application, the market is segmented into Oncology, Diabetes, Hematology, Gastroenterology and Others. Based on End-use, the market is segmented into Hospitals, Specialty Clinics and Ambulatory Surgical Centers. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smiths Group PLC, Fresenius SE & Co. KGaA, B. Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company, Terumo Corporation, Abbott Laboratories, Avante Health Solutions, ICU Medical, Inc., and Ace Medical Co., Ltd.
Scope of the Study
Market Segments Covered in the Report:
By End Use
- Specialty Clinics
- Ambulatory Surgical Centers
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Smiths Group PLC
- Fresenius SE & Co. KGaA
- B. Braun Melsungen AG
- Baxter International, Inc.
- Becton, Dickinson and Company
- Terumo Corporation
- Abbott Laboratories
- Avante Health Solutions
- ICU Medical, Inc.
- Ace Medical Co., Ltd.
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free